Instant Blood-Mediated Inflammatory Reaction (IBMIR) is a major cause of graft loss during pancreatic islet transplantation, leading to a low efficiency of this treatment method and significantly limiting its broader clinical use. Within the procedure, transplanted islets obstruct intrahepatic portal vein branches and consequently restrict blood supply of downstream lying liver tissue, resulting typically in ischemic necrosis. The extent of ischemic lesions is influenced by mechanical obstruction and inflammation, as well as subsequent recanalization and regeneration capacity of recipient liver tissue. Monitoring of immediate liver perfusion impairment, which is directly related to the intensity of post-transplant inflammation and thrombosis (IBMIR), is essential for improving therapeutic and preventive strategies to improve overall islet graft survival. In this study, we present a new experimental model enabling direct quantification of liver perfusion impairment after pancreatic islet transplantation using ligation of hepatic arteries followed by contrast-enhanced magnetic resonance imaging (MRI). The ligation of hepatic arteries prevents the contrast agent from circumventing the portal vein obstruction and enables to discriminate between well-perfused and non-perfused liver tissue. Here we demonstrate that the extent of liver ischemia reliably reflects the number of transplanted islets. This model represents a useful tool for in vivo monitoring of biological effect of IBMIR-alleviating interventions as well as other experiments related to liver ischemia. This technical paper introduces a novel technique and its first application in experimental animals.

1st Faculty of Medicine Charles University Prague Czech Republic

Diabetes Center Institute for Clinical and Experimental Medicine Prague Czech Republic

Institute of Biophysics and Informatics Charles University Prague Czech Republic

Laboratory of Pancreatic Islets Institute for Clinical and Experimental Medicine Prague Czech Republic

Magnetic Resonance Unit Radiodiagnostic and Interventional Radiology Department Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV.. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–238. doi:10.1056/NEJM200007273430401. PubMed DOI

Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318–1330. doi:10.1056/NEJMoa061267. PubMed DOI

Moberg L, Korsgren O, Nilsson B.. Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol. 2005;142(1):125–131. doi:10.1111/j.1365-2249.2005.02883.x. PubMed DOI PMC

Delaune V, Berney T, Lacotte S, Toso C. Intraportal islet transplantation: the impact of the liver microenvironment. Transpl Int. 2017;30(3):227–238. doi:10.1111/tri.12919. PubMed DOI

Eich T, Eriksson O, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med. 2007;356:2754–2755. doi:10.1056/NEJMc070201. PubMed DOI

Eich T, Eriksson O, Sundin A, Estrada S, Brandhorst D, Brandhorst H, Langstrom B, Nilsson B, Korsgren O, Lundgren T. Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation. 2007;84:893–898. doi:10.1097/01.tp.0000284730.86567.9f. PubMed DOI

Korsgren O, Lundgren T, Felldin M, Foss A, Isaksson B, Permert J, Persson NH, Rafael E, Ryden M, Salmela K, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia. 2008;51(2):227–232. doi:10.1007/s00125-007-0868-9. PubMed DOI

Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, Felldin M, Källen R, Salmela K, Tibell A, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes. 2005;54:1755–1762. doi:10.2337/diabetes.54.6.1755. PubMed DOI

Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Källen R, Østraat Ø, Salmela K, Tibell A, Tufveson G, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039–2045. doi:10.1016/s0140-6736(02)12020-4. PubMed DOI

Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 2002;51(6):1779–1784. doi:10.2337/diabetes.51.6.1779. PubMed DOI

Moberg L, Olsson A, Berne C, Felldin M, Foss A, Källen R, Salmela K, Tibell A, Tufveson G, Nilsson B, et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation. 2003;76(9):1285–1288. doi:10.1097/01.TP.0000098905.86445.0F. PubMed DOI

Nilsson B, Ekdahl KN, Korsgren O. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant. 2011;16(6):620–626. doi:10.1097/MOT.0b013e32834c2393. PubMed DOI

Cabric S, Sanchez J, Lundgren T, Foss A, Felldin M, Källen R, Salmela K, Tibell A, Tufveson G, Larsson R, et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes. 2007;56(8):2008–2015. doi:10.2337/db07-0358. PubMed DOI

Teramura Y, Iwata H. Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug Chem. 2008;19(7):1389–1395. doi:10.1021/bc800064t. PubMed DOI

Sakata N, Hayes P, Tan A, Chan NK, Mace J, Peverini R, Sowers L, Pearce WJ, Chinnock R, Obenaus A, et al. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation. 2009;87:825–830. doi:10.1097/TP.0b013e318199c7d2. PubMed DOI PMC

Lee S, Charters AC, Orloff MJ. Simplified technic for orthotopic liver transplantation in the rat. Am J Surg. 1975;130:38–40. doi:10.1016/0002-9610(75)90453-5. PubMed DOI

Hori T, Gardner LB, Chen F, Baine AM, Hata T, Uemoto S, Nguyen JH. Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat. J Invest Surg. 2012;25(4):242–252. doi:10.3109/08941939.2011.636476. PubMed DOI PMC

Quesenberry KE, Carpenter JW. Ferrets, rabbits, and rodents: clinical medicine and surgery. St. Louis (MO): Elsevier; 2012.

Saudek F, Jirak D, Girman P, Herynek V, Dezortova M, Kriz J, Peregrin J, Berkova Z, Zacharovova K, Hajek M. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010;90(12):1602–1606. doi:10.1097/tp.0b013e3181ffba5e. PubMed DOI

Jirak D, Kriz J, Strzelecki M, Yang J, Hasilo C, White DJ, Foster PJ. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. MAGMA. 2009;22(4):257–265. doi:10.1007/s10334-009-0172-4. PubMed DOI

Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med. 2006;12(1):144–148. doi:10.1038/nm1316. PubMed DOI

Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, Moore A. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes. 2006;55(9):2419–2428. doi:10.2337/db06-0484. PubMed DOI

Kriz J, Jirak D, White D, Foster P. Magnetic resonance imaging of pancreatic islets transplanted into the right liver lobes of diabetic mice. Transplant Proc. 2008;40(2):444–448. doi:10.1016/j.transproceed.2008.02.018. PubMed DOI

Berkova Z, Jirak D, Zacharovova K, Kriz J, Lodererova A, Girman P, Koblas T, Dovolilova E, Vancova M, Hajek M, et al. Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance. Transplantation. 2008;85(1):155–159. doi:10.1097/01.tp.0000297247.08627.ff. PubMed DOI

Kriz J, Jirak D, Girman P, Berkova Z, Zacharovova K, Honsova E, Lodererova A, Hajek M, Saudek F. Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation. 2005;80(11):1596–1603. doi:10.1097/01.tp.0000183959.73681.b9. PubMed DOI

Jirak D, Kriz J, Herynek V, Andersson B, Girman P, Burian M, Saudek F, Hajek M. MRI of transplanted pancreatic islets. Magn Reson Med. 2004;52(6):1228–1233. doi:10.1002/mrm.20282. PubMed DOI

Herynek V, Berkova Z, Dovolilova E, Jirak D, Kriz J, Girman P, Saudek F, Hajek M. Improved detection of pancreatic islets in vivo using double contrast. Contrast Media Mol Imaging. 2011;6(4):308–313. doi:10.1002/cmmi.432. PubMed DOI

Girman P, Kriz J, Balaz P. Rat experimental transplantation surgery: a practical guide. Basel (CH): Springer; 2015.

Kriz J, Jirak D, Berkova Z, Herynek V, Lodererova A, Girman P, Habart D, Hajek M, Saudek F. Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging. Transpl Int. 2012;25(2):250–260. doi:10.1111/j.1432-2277.2011.01403.x. PubMed DOI